Drug recall · October 22, 2014
Vaseretic recall
Why: Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada
- Lots / codes
VASERETIC 10-25MG TAB 100CT Lot # 12J022P exp. 9/30/2014 VASERETIC 10-25MG TAB 100CT Lot # 13G047P exp. 07/31/2015
- Quantity
- 205,853 bottles
- Company
- Valeant Pharmaceuticals North America LLC, Bridgewater, NJ
- Distribution
- Nationwide
- Initiated
- May 21, 2014 · Voluntary: Firm initiated
- Classified
- October 10, 2014
- Reported
- October 22, 2014
- Ended
- August 4, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.